Fibulin-1 has previously shown the ability to inhibit cell migration, invasion, and motility in melanoma, epidermoid carcinoma, and breast carcinoma cell lines through inhibition of ERK activation based on fibronectin-specific mechanisms (65). This evidence concerns the gene FN1 and melanoma.